Member

András Tivadar KULJA

EPP · Hungary

Group: EPP PPE
Country: Hungary
Roll-call participation: 61.2 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line: 86.4 %ⓘ of 3 628 votes where the group had a line · EPP median 93.6 %

More facts (5)

National party: TISZA Tisztelet és Szabadság Párt
In office: Since 16 Jul 2024
Against clear line: 387 of 3 470 votesⓘ
Committees: ENVI (vice-chair), SANT
Member id: 256864

National party: TISZA Tisztelet és Szabadság Párt
In office: Since 16 Jul 2024
Against clear line: 387 of 3 470 votesⓘ
Committees: ENVI (vice-chair), SANT
Member id: 256864

Cite this page

EP profile

Link to this page

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Period Whole term 2024 (from July)2025 2026

Custom dates

Votes Final votes620 All roll calls5 928

Roll-call participation ⓘ

61.2 %

3 628 of 5 928 roll calls while in office

EPP median: 89.9 % (−28.7 pts)

Chamber median: 90.2 %

With majority line ⓘ

86.4 %

3 133 of 3 628 votes where their group had a line

EPP median: 93.6 % (−7.3 pts)

Against clear line ⓘ

11.2 %

387 of 3 470 votes where their group had a clear line

184 opposite (for ↔ against), 200 abstained against the line, 3 voted for or against when the line was to abstain

Abstention ⓘ

7.3 %

266 of 3 628 votes cast

Participation 61.2 % — EPP median 89.9 %, 196 members.ⓘ

Data as a table

Participation among the 196 members of the EPP with enough votes.
Figure	Participation
András Tivadar KULJA	61.2 %
EPP median	89.9 %
Lowest in the group	17.0 %
Highest in the group	99.6 %
Members	196

With majority line 86.4 % — EPP median 93.6 %, 196 members.ⓘ

Data as a table

With majority line among the 196 members of the EPP with enough votes.
Figure	With majority line
András Tivadar KULJA	86.4 %
EPP median	93.6 %
Lowest in the group	70.2 %
Highest in the group	99.5 %
Members	196

Whole term, 5 928 roll-call votes. The dots are the other members of EPP; no ranks.
“No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Show Final votes All roll calls

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
Date	Decision	Result	Position	Majority line
11 Mar 2026	Recommendation on enhanced EU-Canada cooperation in the current geopolitical context, including the threats to Canada’s economic stability and sovereignty	Adopted 482 for, 108 against, 42 abstained	Position: No vote recorded	Majority line: For
11 Mar 2026	Tackling barriers to the single market for defence	Adopted 393 for, 169 against, 67 abstained	Position: No vote recorded	Majority line: For
11 Mar 2026	Flagship European defence projects of common interest	Adopted 448 for, 122 against, 38 abstained	Position: No vote recorded	Majority line: For
10 Mar 2026	Harmonising certain aspects of insolvency law	Passed 498 for, 90 against, 28 abstained	Position: No vote recorded	Majority line: For
10 Mar 2026	Establishing an EU talent pool	Passed 414 for, 182 against, 21 abstained	Position: No vote recorded	Majority line: For
10 Mar 2026	Increased efficiency of the External Action Guarantee	Passed 441 for, 105 against, 81 abstained	Position: No vote recorded	Majority line: For
10 Mar 2026	European Union regulatory fitness and subsidiarity and proportionality – report on Better Law-Making covering 2023 and 2024	Adopted 493 for, 92 against, 44 abstained	Position: No vote recorded	Majority line: For
10 Mar 2026	Housing crisis in the European Union with the aim of proposing solutions for decent, sustainable and affordable housing	Adopted 367 for, 166 against, 84 abstained	Position: No vote recorded	Majority line: For
10 Mar 2026	Public access to documents - report 2022 - 2024	Adopted 602 for, 9 against, 8 abstained	Position: No vote recorded	Majority line: For
10 Mar 2026	Copyright and generative artificial intelligence – opportunities and challenges	Adopted 460 for, 71 against, 88 abstained	Position: No vote recorded	Majority line: For
10 Mar 2026	Fisheries management approaches for safeguarding sensitive species, tackling invasive species and benefiting local economies	Adopted 528 for, 21 against, 62 abstained	Position: No vote recorded	Majority line: For
10 Mar 2026	The upcoming European Research Area (ERA) Act	Adopted 399 for, 78 against, 69 abstained	Position: No vote recorded	Majority line: For
24 Feb 2026	Four years of Russia’s war of aggression against Ukraine and European contributions to a just peace and sustained security for Ukraine	Adopted 437 for, 82 against, 70 abstained	Position: No vote recorded	Majority line: For
12 Feb 2026	Cooperation among enforcement authorities regarding unfair trading practices in the agri-food supply chain	Passed 555 for, 0 against, 26 abstained	Position: No vote recorded	Majority line: For
12 Feb 2026	Post-election situation in Uganda and threats against opposition leader Bobi Wine	Adopted 514 for, 3 against, 56 abstained	Position: No vote recorded	Majority line: For
12 Feb 2026	Systemic oppression, inhumane conditions and arbitrary detentions by the regime in Iran	Adopted 524 for, 3 against, 41 abstained	Position: No vote recorded	Majority line: For
12 Feb 2026	Targeted expulsions of foreign journalists and foreign Christians in Türkiye under national security pretexts	Adopted 502 for, 2 against, 59 abstained	Position: No vote recorded	Majority line: For
12 Feb 2026	Developing a new EU anti-poverty strategy	Adopted 385 for, 141 against, 53 abstained	Position: No vote recorded	Majority line: For
12 Feb 2026	Addressing subcontracting chains and the role of intermediaries in order to protect workers’ rights	Adopted 332 for, 209 against, 33 abstained	Position: No vote recorded	Majority line: For
12 Feb 2026	Recommendation to the Council on EU priorities for the 70th session of the UN Commission on the Status of Women	Adopted 340 for, 141 against, 68 abstained	Position: No vote recorded	Majority line: For
12 Feb 2026	Situation in Northeast Syria, the violence against civilians and the need to maintain a sustainable ceasefire	Adopted 363 for, 71 against, 81 abstained	Position: No vote recorded	Majority line: For
11 Feb 2026	Regulation implementing enhanced cooperation on the establishment of the Ukraine Support Loan for 2026 and 2027	Passed 458 for, 140 against, 44 abstained	Position: Against ≠ group	Majority line: For
11 Feb 2026	Amending Regulation (EU) 2024/792 establishing the Ukraine Facility	Passed 473 for, 140 against, 32 abstained	Position: Against ≠ group	Majority line: For
11 Feb 2026	Amending the multiannual financial framework for the years 2021 to 2027	Consent given 490 for, 130 against, 32 abstained	Position: Against ≠ group	Majority line: For
11 Feb 2026	Mobilisation of the European Globalisation Adjustment Fund: application EGF/2025/006 BE/Audi – Belgium	Passed 593 for, 55 against, 9 abstained	Position: For	Majority line: For
11 Feb 2026	Genetically modified soybean DBN-09004-6	Objection passed 461 for, 169 against, 22 abstained	Position: For	Majority line: Against
11 Feb 2026	Genetically modified maize T25 (ACS-ZMØØ3-2)	Objection passed 462 for, 169 against, 22 abstained	Position: For	Majority line: Against
11 Feb 2026	Genetically modified cotton T304-40	Objection passed 428 for, 156 against, 22 abstained	Position: For	Majority line: Against
11 Feb 2026	Genetically modified cotton GHB614 × LLCotton25	Objection passed 463 for, 164 against, 21 abstained	Position: For	Majority line: Against
11 Feb 2026	Interim report in view of the consent procedure on the Agreement establishing an association between the EU and the Principality of Andorra and the Republic of San Marino	Interim report adopted 552 for, 24 against, 75 abstained	Position: For	Majority line: For
11 Feb 2026	EU strategic defence and security partnerships	Adopted 440 for, 119 against, 85 abstained	Position: No vote recorded	Majority line: For
10 Feb 2026	Establishment of a list of safe countries of origin at Union level	Passed 408 for, 184 against, 60 abstained	Position: For	Majority line: For
10 Feb 2026	Application of the ‘safe third country’ concept	Passed 396 for, 226 against, 30 abstained	Position: For	Majority line: For
10 Feb 2026	Amending regulations on agricultural products as regards market rules and sectoral support measures in the wine sector and for aromatised wine products	Passed 625 for, 15 against, 11 abstained	Position: For	Majority line: For
10 Feb 2026	Amending the Measuring Instruments Directive	Passed 594 for, 25 against, 23 abstained	Position: For	Majority line: For
10 Feb 2026	Bilateral safeguard clause of the EU-Mercosur Partnership Agreement and the EU-Mercosur Interim Trade Agreement for agricultural products	Passed 483 for, 102 against, 67 abstained	Position: Against ≠ group	Majority line: For
10 Feb 2026	Framework for achieving climate neutrality	Passed 413 for, 226 against, 12 abstained	Position: Against	Majority line: For
10 Feb 2026	European Union designs (codification)	Passed 613 for, 5 against, 29 abstained	Position: For	Majority line: For
10 Feb 2026	European Central Bank – annual report 2025	Adopted 443 for, 71 against, 117 abstained	Position: For	Majority line: For
22 Jan 2026	Motion of censure on the Commission	Rejected 165 for, 390 against, 10 abstained	Position: No vote recorded	Majority line: Against
22 Jan 2026	Conviction and imminent sentencing of Jimmy Lai in Hong Kong	Adopted 503 for, 9 against, 100 abstained	Position: No vote recorded	Majority line: For
22 Jan 2026	Case of Joseph Figueira Martin in the Central African Republic	Adopted 582 for, 0 against, 35 abstained	Position: No vote recorded	Majority line: For
22 Jan 2026	Drones and new systems of warfare – the EU’s need to adapt to be fit for today’s security challenges	Adopted 483 for, 68 against, 76 abstained	Position: No vote recorded	Majority line: For
22 Jan 2026	Choice of performance indicators for audit and budgetary control in the context of financing measures to support the implementation of future European competitiveness	Adopted 318 for, 247 against, 67 abstained	Position: No vote recorded	Majority line: For
22 Jan 2026	European technological sovereignty and digital infrastructure	Adopted 471 for, 68 against, 71 abstained	Position: No vote recorded	Majority line: For
22 Jan 2026	Brutal repression against protesters in Iran	Adopted 562 for, 9 against, 57 abstained	Position: No vote recorded	Majority line: For
22 Jan 2026	Attempted takeover of Lithuania’s public broadcaster and the threat to democracy in Lithuania	Adopted 385 for, 165 against, 35 abstained	Position: No vote recorded	Majority line: For
21 Jan 2026	Air passenger rights	Amendments 1 + 243 (voted as one) adopted 632 for, 15 against, 9 abstained	Position: For	Majority line: For
21 Jan 2026	EU-Bosnia and Herzegovina Agreement on operational activities carried out by the European Border and Coast Guard Agency in Bosnia and Herzegovina	Consent given 565 for, 83 against, 14 abstained	Position: For	Majority line: For
21 Jan 2026	Enhanced cooperation on the establishment of a Loan for Ukraine	Consent given 499 for, 135 against, 24 abstained	Position: Against ≠ group	Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 24 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table

Roll calls held at each sitting while in office and how many of them the member voted in.
Sitting	Roll calls	Voted in
17 Jul 2024	23	23
18 Jul 2024	1	1
16 Sept 2024	2	2
18 Sept 2024	2	2
19 Sept 2024	92	92
7 Oct 2024	2	2
8 Oct 2024	1	1
9 Oct 2024	18	18
10 Oct 2024	4	4
21 Oct 2024	2	2
22 Oct 2024	10	10
23 Oct 2024	129	129
24 Oct 2024	13	12
13 Nov 2024	2	2
14 Nov 2024	36	36
25 Nov 2024	2	1
26 Nov 2024	18	18
27 Nov 2024	11	11
28 Nov 2024	57	0
17 Dec 2024	13	11
18 Dec 2024	33	32
19 Dec 2024	45	6
20 Jan 2025	2	2
21 Jan 2025	1	1
22 Jan 2025	2	2
23 Jan 2025	45	40
10 Feb 2025	1	0
11 Feb 2025	32	32
12 Feb 2025	10	10
13 Feb 2025	30	26
10 Mar 2025	2	2
11 Mar 2025	9	0
12 Mar 2025	228	172
13 Mar 2025	24	22
31 Mar 2025	3	0
1 Apr 2025	35	35
2 Apr 2025	251	60
3 Apr 2025	62	54
5 May 2025	5	5
6 May 2025	10	3
7 May 2025	220	181
8 May 2025	103	88
21 May 2025	2	2
22 May 2025	53	28
16 Jun 2025	2	0
17 Jun 2025	41	0
18 Jun 2025	91	0
19 Jun 2025	87	0
7 Jul 2025	1	0
8 Jul 2025	55	29
9 Jul 2025	134	101
10 Jul 2025	36	35
8 Sept 2025	1	1
9 Sept 2025	101	91
10 Sept 2025	34	31
11 Sept 2025	69	23
6 Oct 2025	2	2
7 Oct 2025	5	5
8 Oct 2025	55	47
9 Oct 2025	65	47
20 Oct 2025	3	1
21 Oct 2025	13	13
22 Oct 2025	186	142
23 Oct 2025	55	0
13 Nov 2025	267	209
24 Nov 2025	3	1
25 Nov 2025	75	22
26 Nov 2025	100	80
27 Nov 2025	125	90
15 Dec 2025	4	4
16 Dec 2025	66	20
17 Dec 2025	43	0
18 Dec 2025	42	27
20 Jan 2026	67	40
21 Jan 2026	112	5
22 Jan 2026	58	0
9 Feb 2026	2	0
10 Feb 2026	38	30
11 Feb 2026	13	12
12 Feb 2026	141	0
24 Feb 2026	43	0
9 Mar 2026	1	0
10 Mar 2026	197	0
11 Mar 2026	60	0
12 Mar 2026	34	0
25 Mar 2026	3	0
26 Mar 2026	69	1
27 Apr 2026	2	0
28 Apr 2026	225	0
29 Apr 2026	296	254
30 Apr 2026	68	58
18 May 2026	4	4
19 May 2026	3	3
20 May 2026	96	95
21 May 2026	98	97
15 Jun 2026	2	0
16 Jun 2026	40	37
17 Jun 2026	127	121
18 Jun 2026	77	76
6 Jul 2026	2	0
7 Jul 2026	72	67
8 Jul 2026	144	108
9 Jul 2026	67	67
14 Sept 2026	1	1
15 Sept 2026	155	149
16 Sept 2026	80	78
17 Sept 2026	124	124

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
Select	Member	Group	Country	Agreement	Baseline
Select Eszter LAKOS	Eszter LAKOS	EPP	Hungary	99 % of 3 274 shared	89 %
Select Dóra DÁVID	Dóra DÁVID	EPP	Hungary	99 % of 3 586 shared	89 %
Select Gabriella GERZSENYI	Gabriella GERZSENYI	EPP	Hungary	99 % of 2 356 shared	89 %
Select Kinga KOLLÁR	Kinga KOLLÁR	EPP	Hungary	99 % of 3 067 shared	89 %
Select Zoltán TARR	Zoltán TARR Former member	EPP	Hungary	97 % of 1 796 shared	89 %
Select Péter MAGYAR	Péter MAGYAR Former member	EPP	Hungary	93 % of 682 shared	89 %
Select Willemien KONING	Willemien KONING	EPP	Netherlands	89 % of 1 213 shared	89 %
Select Marie-Sophie CHRIST	Marie-Sophie CHRIST	EPP	Germany	88 % of 1 291 shared	89 %
Select Manfred WEBER	Manfred WEBER	EPP	Germany	88 % of 2 850 shared	89 %
Select Martine KEMP	Martine KEMP	EPP	Luxembourg	87 % of 2 916 shared	89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
Select	Member	Group	Country	Agreement	Baseline
Select Jérémy DECERLE	Jérémy DECERLE	Renew	France	79 % of 1 750 shared	82 %
Select Ivars IJABS	Ivars IJABS	Renew	Latvia	78 % of 2 812 shared	82 %
Select Sophie WILMÈS	Sophie WILMÈS	Renew	Belgium	78 % of 2 466 shared	82 %
Select Urmas PAET	Urmas PAET	Renew	Estonia	78 % of 3 122 shared	82 %
Select Hilde VAUTMANS	Hilde VAUTMANS	Renew	Belgium	78 % of 3 514 shared	82 %
Select Nathalie LOISEAU	Nathalie LOISEAU	Renew	France	78 % of 2 822 shared	82 %
Select Eugen TOMAC	Eugen TOMAC	Renew	Romania	77 % of 2 398 shared	82 %
Select Gilles BOYER	Gilles BOYER	Renew	France	77 % of 3 612 shared	82 %
Select Benoit CASSART	Benoit CASSART	Renew	Belgium	77 % of 3 409 shared	82 %
Select Grégory ALLIONE	Grégory ALLIONE	Renew	France	77 % of 3 203 shared	82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
Body	Role	From	To
Committee on the Environment, Climate and Food SafetyENVI Committee	Vice-chair	20 Jan 2025	now
Committee on Public HealthSANT Committee	Member	23 Jan 2025	now
Delegation for relations with CanadaD-CA Delegation	Substitute	12 Jun 2026	now
Delegation for relations with the Korean PeninsulaDKOR Delegation	Substitute	19 Sept 2024	now
Intergroup on Anti-CorruptionIG10-01 Intergroup / working group	Member	16 Jan 2025	now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working group	Member	27 Jan 2025	now
Intergroup on DisabilityIG10-10 Intergroup / working group	Member	11 Mar 2025	now
Intergroup on Mental HealthIG10-17 Intergroup / working group	Member	5 Feb 2025	now
Intergroup on Traditional Minorities, National Communities and LanguagesIG10-25 Intergroup / working group	Member	5 Feb 2025	now
Committee on Employment and Social AffairsEMPL Committee	Substitute	19 Jul 2024	11 Jun 2026

Show all 13 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
Dossier	Role	Committee	Date
No dossier named	Official delegation	SANT	2 Sept 2026
No dossier named	Official delegation	SANT	22 Apr 2026
No dossier named	Official delegation	SANT	29 Jan 2026
An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector	Shadow rapporteur	SANT	8 Oct 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795	Shadow rapporteur for an opinion	ENVI	19 Jun 2025
No dossier named	Official delegation	ENVI	17 Mar 2025
Implementation and delivery of the Sustainable Development Goals in view of the 2025 High-Level Political Forum	Shadow rapporteur	ENVI	24 Feb 2025
Safety of toys	Shadow rapporteur for an opinion	ENVI	14 Nov 2024
No dossier named	Official delegation		25 Oct 2024
No dossier named	Official delegation		11 Sept 2024

Show all 11 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

38 contributions recorded, 2 written statements; 4 on behalf of their group; 52 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
Date	Debate	Kind	Verbatim
17 Sept 2026	Protecting people’s health against toxic substances (debate)	Speech · 1 min	Read
17 Sept 2026	An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector (debate) on behalf of EPP	Speech · 2 min	Read
15 Sept 2026	Findings and recommendations of the Special Committee on the European Democracy Shield (debate)	Speech · 1 min	Read
15 Sept 2026	Devastating heatwaves, wildfires and droughts in Europe: lessons from summer 2026 (debate)	Speech · 1 min	Read
11 Feb 2026	Rule of law, fundamental rights and misuse of EU funds in Slovakia: the need for an EU response (debate)	Speech · 1 min	Read
19 Jan 2026	Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate) on behalf of EPP	Speech · 2 min	Read
16 Dec 2025	Presentation of the EU Cardiovascular Health Plan (debate)	Speech · 1 min	Read
16 Dec 2025	Presentation of the EU Cardiovascular Health Plan (debate)	Speech · 2 min	Read
15 Dec 2025	Impact of the geopolitical situation on European patients and their access to medicines (debate)	Speech · 2 min	Read
23 Oct 2025	Breast cancer: the importance of screening (debate)	Statement	Read

Show all 38 recent contributions

Questions and motions, 14

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
Date	Title	Kind	Answer
18 May 2026	Access to reliable clinical performance data and regulatory oversight of CGM systems in the EU E-10-2026-002029	Written question	17 Jul 2026
11 Feb 2026	Request for an assessment of land confiscation practices and of the criminalisation of public criticism of historical legislation in Slovakia P-10-2026-000603	Priority written questionwith 6 co-authors	30 Apr 2026
22 Dec 2025	Serious concerns regarding compliance with European values and EU law in Slovakia E-10-2025-005054	Written questionwith 12 co-authors	21 Apr 2026
20 Dec 2025	Implementation of EU anti-poverty strategy based on accurate data E-10-2025-005037	Written questionwith 5 co-authors	25 Feb 2026
23 Sept 2025	Newborn screening for access to advanced life-saving therapies E-10-2025-003675	Written questionwith 3 co-authors	21 Nov 2025
17 Jun 2025	The role of local authorities in addressing the financial and operational challenges posed by PFAS and other persistent chemical contaminants in Europe E-10-2025-002429	Written questionwith 20 co-authors	26 Aug 2025
29 Apr 2025	Strengthening workplace health and safety to prevent sudden cardiac arrest deaths E-10-2025-001716	Written question	13 Jun 2025
26 Feb 2025	Rare diseases P-10-2025-000845	Priority written questionwith 7 co-authors	2 May 2025
21 Feb 2025	Commission’s response to the incomplete implementation of the UN Convention on the Rights of Persons with Disabilities in Member States E-10-2025-000810	Written questionwith 50 co-authors	27 May 2025
20 Jan 2025	Infection prevention and action against antimicrobial resistance, including innovative therapies E-10-2025-000213	Written question	18 Mar 2025
6 Jan 2025	Need for diversified, sustainable pain management in the EU to reduce reliance on pharmaceuticals and strengthen supply chains, thus enhancing sustainable healthcare E-10-2025-000010	Written question	29 Apr 2025
12 Dec 2024	Understaffing of healthcare professionals in EU public health systems E-10-2024-002877	Written question	24 Feb 2025
20 Nov 2024	Universal health coverage – global health challenges E-10-2024-002589	Written question	30 Jan 2025
17 Sept 2024	MOTION FOR A RESOLUTION on the devastating floods in central and eastern Europe, the loss of lives and the EU’s preparedness to act on such disasters exacerbated by climate change B-10-2024-0057	Motion for a resolutionwith 24 co-authors	—

Amendments tabled in committee, 52

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
Date	Text amended	Committee	Amendments
11 Sept 2026	Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014	SANT	26
11 Sept 2026	Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154	SANT	5
28 Jul 2026	Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891	SANT	3
28 Jul 2026	Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887	SANT	9
28 Jul 2026	Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890	SANT	1
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936	CJ53	5
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937	CJ53	9
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938	CJ53	1
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939	CJ53	6
13 Jul 2026	Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934	CJ53	6

Show all 52 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

Group European People’s Party EPP · Centre-right · Christian democracy, conservatism

National delegation

Delegation Hungary National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Permalink: https://news.eu-parl.st-solutions.dev/members/256864?docs=all&page=5&vscope=final
Official source: Member’s profile, European Parliament
Data source: EP Open Data: member record
Licensed CC BY 4.0.
Data version: data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved: 25 September 2026

Cite as

EU Parl Watch Research (2026). “András Tivadar KULJA”. Member record. memberId 256864. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/256864?docs=all&page=5&vscope=final (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/256864. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/256864?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.

BibTeX

@misc{epw-member-256864,
  author = {{EU Parl Watch Research}},
  title = {{András Tivadar KULJA}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/256864?docs=all&page=5&vscope=final}},
  url = {https://news.eu-parl.st-solutions.dev/members/256864?docs=all&page=5&vscope=final},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 256864. Official source: https://www.europarl.europa.eu/meps/en/256864. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}